Yeo C K, Hapizah M N, Khalid B A K, Wan Nazainimoon W M, Khalid Y
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, 56000 Cheras, Kuala Lumpur.
Med J Malaysia. 2004 Jun;59(2):185-9.
Diabetes mellitus is an important coronary artery disease risk factor. The presence of microalbuminuria, which indicates renal involvement in diabetic patients, is associated with an increased cardiovascular risk. There are suggestions that diabetic patients with microalbuminuria have more adverse risk profile such as higher ambulatory blood pressure and total cholesterol levels to account for the increased cardiovascular morbidity and mortality. QT dispersion is increasingly being recognized as a prognostic factor for coronary artery disease and sudden death. Some studies have suggested that QT dispersion is an important predictor of mortality in Type II diabetic patients. Our cross sectional study was to compare the QT dispersion and 24 hour ambulatory blood pressure monitoring between diabetic patients with microalbuminuria and those without microalbuminuria. Diabetic patients with overt coronary artery disease were excluded from the study. A total of 108 patients were recruited of which 57 patients had microalbuminuria and 51 were without microalbuminuria. The mean value of QT dispersion was significantly higher in patients with microalbuminuria than in patients without microalbuminuria (58.9 +/- 27.9 ms vs. 47.1 +/- 25.0 ms, p < 0.05). The mean 24 hour systolic and diastolic blood pressures were significantly higher in patients with microalbuminuria than in patients without microalbuminuria (129.5 +/- 12.3 mm Hg vs 122.3 +/- 10.2 mm Hg, p < 0.05 and 78.4 +/- 6.9 mm Hg vs 75.3 +/- 6.8 mm Hg, p < 0.05, respectively). Our study suggests that QT dispersion prolongation, related perhaps to some autonomic dysfunction, is an early manifestation of cardiovascular aberration in diabetic patients with microalbuminuria. The higher blood pressure levels recorded during a 24-hour period min diabetics with microalbuminuria could also possibly account for the worse cardiovascular outcome in this group of patients.
糖尿病是一种重要的冠状动脉疾病危险因素。微量白蛋白尿的存在表明糖尿病患者存在肾脏受累情况,这与心血管风险增加相关。有迹象表明,患有微量白蛋白尿的糖尿病患者具有更多不良风险特征,如更高的动态血压和总胆固醇水平,这解释了心血管发病率和死亡率的增加。QT离散度越来越被认为是冠状动脉疾病和猝死的一个预后因素。一些研究表明,QT离散度是II型糖尿病患者死亡率的一个重要预测指标。我们的横断面研究旨在比较有微量白蛋白尿的糖尿病患者和无微量白蛋白尿的糖尿病患者之间的QT离散度及24小时动态血压监测情况。患有明显冠状动脉疾病的糖尿病患者被排除在研究之外。共招募了108名患者,其中57名患者有微量白蛋白尿,51名患者无微量白蛋白尿。有微量白蛋白尿的患者的QT离散度平均值显著高于无微量白蛋白尿的患者(58.9±27.9毫秒对47.1±25.0毫秒,p<0.05)。有微量白蛋白尿的患者的24小时平均收缩压和舒张压显著高于无微量白蛋白尿的患者(分别为129.5±12.3毫米汞柱对122.3±10.2毫米汞柱,p<0.05;78.4±6.9毫米汞柱对75.3±6.8毫米汞柱,p<0.05)。我们的研究表明,QT离散度延长可能与某些自主神经功能障碍有关,是有微量白蛋白尿的糖尿病患者心血管异常的早期表现。在24小时期间记录到的有微量白蛋白尿的糖尿病患者较高的血压水平也可能解释了该组患者较差的心血管结局。